SecBot SecBot
SECBOTREPLAY Home › Report › FULC

FULC · Montanova Capital exits FULC

Fulcrum Therapeutics, Inc. · SC 13G/A filed Nov 13, 2026 at 16:04 ET

At the news

NEUTRALIMPACT 3/10

SC 13G/A filed Nov 13, 2026 at 16:04 ET

Montanova Capital LLC and affiliated entities filed an amended Schedule 13G disclosing they no longer hold any shares of Fulcrum Therapeutics as of September 30, 2026, down from a prior stake. This complete exit by a passive investment manager removes a known holder but does not signal activist intent.

  • Montanova Capital, Averill Master Fund, and Aaron Cowen filed Amendment No. 3 to Schedule 13G on November 13, 2026
  • The filing reports 0 shares and 0% beneficial ownership as of September 30, 2026
  • The prior filing (not provided) had disclosed a non-zero stake; this amendment reflects a complete exit
  • The filing states securities were held in the ordinary course and not for control purposes

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access